Affinivax launches novel conjugate vaccine for global impact on infectious diseases
Affinivax announced its launch with a $4 million investment from the Bill & Melinda Gates Foundation. This commitment from the Gates Foundation also includes additional investments in Affinivax based on the achievement of future success-based milestones. October 30, 2014